Provided by Tiger Trade Technology Pte. Ltd.

Cytokinetics

77.09
+0.25000.33%
Post-market: 77.090.00000.00%19:30 EDT
Volume:1.21M
Turnover:93.44M
Market Cap:10.72B
PE:-10.73
High:77.99
Open:77.20
Low:75.65
Close:76.84
52wk High:88.31
52wk Low:35.22
Shares:139.02M
Float Shares:138.02M
Volume Ratio:0.77
T/O Rate:0.88%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-7.1827
EPS(LYR):-6.5400
ROE:-572.15%
ROA:-28.09%
PB:-61.78
PE(LYR):-11.79

Loading ...

Analysts Offer Insights on Healthcare Companies: Medtronic (MDT), Ultragenyx Pharmaceutical (RARE) and Cytokinetics (CYTK)

TIPRANKS
·
Aug 20

Cytokinetics Announces Upcoming Presentations at the European Society of Cardiology (Esc) Congress 2026

THOMSON REUTERS
·
Aug 20

Cytokinetics Announces Upcoming Presentations at the European Society of Cardiology (ESC) Congress 2026

GlobeNewswire
·
Aug 20

Top Cytokinetics Executive Makes Attention-Grabbing Move With Insider Stock Sale

TIPRANKS
·
Aug 19

Cytokinetics EVP R&D Malik Fady Ibraham Disposes of 3,500 Common Shares for $265,370

Reuters
·
Aug 19

Cytokinetics Grants New-Hire Equity Awards, Stock Options Priced at $74.13 Per Share

Reuters
·
Aug 19

Cytokinetics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

THOMSON REUTERS
·
Aug 19

Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
Aug 19

Cytokinetics price target raised to $103 from $97 at JPMorgan

TIPRANKS
·
Aug 17

Barclays Reaffirms Their Buy Rating on Cytokinetics (CYTK)

TIPRANKS
·
Aug 14

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
Aug 14

Cytokinetics is Maintained at Overweight by JP Morgan

Dow Jones
·
Aug 13

Cytokinetics Files Patent Suit to Protect MYQORZO Franchise

TIPRANKS
·
Aug 13

Cytokinetics - Files Complaint Against Bristol-Myers Squibb and Myokardia - SEC Filing

THOMSON REUTERS
·
Aug 13

Cytokinetics - Demands Trial by Jury on All Triable Issues - SEC Filing

THOMSON REUTERS
·
Aug 13

Cytokinetics - Seeks Injunction Against Litigation or Infringement Claims on Myqorzo(Aficamten) - SEC Filing

THOMSON REUTERS
·
Aug 13

Cytokinetics Sues Bristol Myers, MyoKardia Seeking Ruling on Myqorzo Patent Dispute

Reuters
·
Aug 13

U.S. Research Roundup-Airbnb, Five Below, Silgan Holdings

Reuters
·
Aug 13

Cytokinetics, Incorporated : JP Morgan Raises Target Price to $103 from $97

THOMSON REUTERS
·
Aug 13

Truist Financial Keeps Their Buy Rating on Cytokinetics (CYTK)

TIPRANKS
·
Aug 13